The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Medifast Inc

NYSE: MED
Last

(U.S.) $41.50

Today's change+0.28 +0.68%
Updated January 24 4:02 PM EST. Delayed by at least 15 minutes.
 

Medifast Inc

NYSE: MED
Last

(U.S.) $41.50

Today's change+0.28 +0.68%
Updated January 24 4:02 PM EST. Delayed by at least 15 minutes.

Medifast Inc up (U.S.)$0.28

Medifast Inc closed up Tuesday by (U.S.)$0.28 or 0.68% to (U.S.)$41.50. Over the last five days, shares have gained 0.34% and are currently 3.82% off of its 52-week high. Over the last year, this stock has outperformed the S&P 500, gaining 42.07%.

Key company metrics

  • Open(U.S.) $41.17
  • Previous close(U.S.) $41.22
  • High(U.S.) $41.59
  • Low(U.S.) $41.00
  • Bid / Ask(U.S.) $40.00 / (U.S.) $44.00
  • YTD % change-0.31%
  • Volume36,772
  • Average volume (10-day)67,534
  • Average volume (1-month)71,851
  • Average volume (3-month)90,909
  • 52-week range(U.S.) $27.12 to (U.S.) $43.15
  • Beta0.54
  • Trailing P/E28.07×
  • P/E 1 year forward21.93×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.28
  • Dividend yield3.08%
  • Trailing EPS(U.S.) $1.48
Updated January 24 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.45%

Based on its net profit margin of 6.45%, Medifast Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.84%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue69717261
Total other revenue--------
Total revenue69717261
Gross profit52535345
Total cost of revenue16181916
Total operating expense60666656
Selling / general / administrative43484740
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income9566
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax9566
Income after tax6344
Income tax, total3222
Net income6344
Total adjustments to net income--------
Net income before extra. items6344
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6344
Inc. avail. to common incl. extra. items6344
Diluted net income6344
Dilution adjustment------0
Diluted weighted average shares12121212
Diluted EPS excluding extraordinary itemsvalue per share0.510.290.360.33
Dividends per sharevalue per share0.250.250.250.25
Diluted normalized EPSvalue per share0.510.290.360.33